Healthcare Services Group Stock Earnings Reports

HCSG reported a strong Q1 2026: revenue of $462.8M (up 3.4% YoY), net income $26.1M, EPS $0.37, and adjusted EBITDA near $39M. Cost of services came in at 83.6% (better than their 86% target), driven by improved service execution, workers' comp/general liability efficiencies (~1% benefit), and lower bad debt. SG&A was $42M (9.4% adjusted), and the effective tax rate was ~24.6%. Cash flow from operations was $43.7M (adjusted $23.4M after payroll accrual), cash and marketable securities were $214.6M, and the $300M revolver remains undrawn; the credit facility was extended to 2031 with improved terms. Management reiterated mid-single-digit revenue growth guidance for 2026 with Q2 revenue guidance of $465M–$475M, continued focus on three priorities: (1) growth via management development, pipeline conversion and retention, (2) cost management through field execution, and (3) cash/contract optimization. Capital allocation remains balanced across organic growth, M&A (targeting smaller tuck-ins ~$20M–$30M) and buybacks; the company accelerated a $75M repurchase program (announced Feb 2026) and repurchased $24M in Q1. Management emphasized strong industry fundamentals driven by a multi-decade demographic tailwind, steady occupancy (~80%), improving workforce availability, and supplier/vendor partnerships to manage cost pressure. They continue to serve Genesis facilities with no payment/operational disruption during the sale process.